Case Study

When Smarter Multi-SKU Commercial Packaging Drives Long-Term Success

Challenge

The client faced a complex challenge: one of their flagship drugs is sold both under their own brand and across 10 generic brands, distributed in 36 distinct SKUs (pharmaceutical presentations).

Their existing packaging process involved managing primary and secondary packaging sequentially, with each primary packaging batch immediately followed by its corresponding secondary packaging.

As the number of product variations continued to grow, this linear approach became less efficient and unsustainable. The company needed a streamlined and agile packaging solution capable of managing their SKU portfolio: Their supply and purchasing team sought a Contract Packager with the expertise to handle complex packaging operations for diverse markets, maintaining the highest levels of efficiency and quality.

The Myonex Solution

Myonex brought a game-changing solution through late-stage differentiation. By starting with a single primary packaging batch, we adapted product references during secondary packaging, customizing each batch to meet the specific requirements of different markets.

We delivered the perfect combination of quality and flexibility. Our adaptable workshops and equipment, coupled with robust processes and anticipated scheduling ensured smooth handling of even the smallest batch sizes.

The comprehensive service offerings included packaging design and sourcing of the different items – vial labeling, variable printing and boxing ops. This holistic approach empowered the client to effectively manage their 36 SKUs, ensuring on-time delivery, cost efficiency, and a simplified supply chain.

Results

Zero Supply Shortages: Myonex successfully packaged 2.7 million units through the year, handling batches ranging from 2,000 to 80,000 units, delivering every order on time. The optimized packaging approach ensured a continuous and reliable supply chain flow.
Uncompromising Quality & Compliance: Our packaging processes strictly adhere to GMP pharmaceutical standards. Quality control certifies that each differentiation step was handled with precision and traceability.
Faster Time-to-Market: The solution helped accelerate time-to-market, increasing the customer’s agility and market responsiveness.
Significant Cost Savings: Consolidating primary packaging and minimizing intermediate stock reduced production costs. Efficient scheduling allowed seamless execution of successive secondary packaging batches within the same workshop, as a cost-effective campaign approach.
Increased Productivity: By outsourcing complex packaging operations, the client’s team was freed up to focus on higher-value tasks, driving greater business impact.
Enhanced lifecycle management: The client gained the ability to adapt swiftly to packaging changes or market demands, saving both time and costs. This flexibility also allowed them to enter new markets, including those with lower sales volumes, more efficiently.

Conclusion

Through Myonex’s innovative late-stage differentiation, a single primary packaging batch was transformed into multiple references, meeting both market demands and regulatory requirements with ease.

Our scalable and cost-effective solution simplified the complexities of multi-reference pharmaceutical packaging while ensuring efficiency and compliance.

Built on trust, transparency, and performance, this collaboration has evolved into a long-term partnership – a cornerstone of any client’s commercial supply chain strategy.

Myonex: Transforming challenges into opportunities for smarter packaging solutions.